FdaApplication
NDA 021926
Identifiers
- fda_app_no: NDA021926
Properties
| Property | Value |
|---|---|
| applicant_name | AZURITY PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2008-04-15 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TREXIMET | NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE | 60MG;EQ 10MG BASE | TABLET;ORAL |
| TREXIMET | NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE | 500MG;EQ 85MG BASE | TABLET;ORAL |
2 products